TP53 and choroid plexus carcinoma: In four of the rare malignancies: childhood ACC, anaplastic rhabdomyosarcoma, choroid plexus carcinoma, and low hypodiploid acute lymphoblastic leukemia, TP53 mutation carriers account for 40–80% of all patients [3–5].